An association between liraglutide treatment and reduction in excessive daytime sleepiness in obese subjects with type 2 diabetes

摘要

BackgroundThe main purpose of the present study is to evaluate whether treatment with long-acting human glucagon-like peptide-1 liraglutide was associated with an improvement of excessive daytime sleepiness (EDS) in obese subjects with type-2 diabetes.